Page 102 - Demo

Chapter 5100References1. Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018, 68, 394-424, doi:10.3322/caac.21492.2. Thrift, A.P. The epidemic of oesophageal carcinoma: Where are we now? Cancer Epidemiol 2016, 41, 88-95, doi:10.1016/j.canep.2016.01.013.3. Lagergren, J.; Smyth, E.; Cunningham, D.; Lagergren, P. Oesophageal cancer. Lancet 2017, 390, 2383-2396, doi:10.1016/S0140-6736(17)31462-9.4. Wagner, A.D.; Syn, N.L.; Moehler, M.; Grothe, W.; Yong, W.P.; Tai, B.C.; Ho, J.; Unverzagt, S. Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev 2017, 8, CD004064, doi:10.1002/14651858.CD004064.pub4.5. Cunningham, D.; Okines, A.F.; Ashley, S. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 2010, 362, 858-859, doi:10.1056/NEJMc0911925.6. Bang, Y.J.; Van Cutsem, E.; Feyereislova, A.; Chung, H.C.; Shen, L.; Sawaki, A.; Lordick, F.; Ohtsu, A.; Omuro, Y.; Satoh, T., et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010, 376, 687-697, doi:10.1016/S0140-6736(10)61121-X.7. Bartel, D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116, 281-297.8. Esquela-Kerscher, A.; Slack, F.J. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006, 6, 259-269, doi:10.1038/nrc1840.9. Lu, J.; Getz, G.; Miska, E.A.; Alvarez-Saavedra, E.; Lamb, J.; Peck, D.; Sweet-Cordero, A.; Ebert, B.L.; Mak, R.H.; Ferrando, A.A., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435, 834-838, doi:10.1038/nature03702.10. Hezova, R.; Kovarikova, A.; Srovnal, J.; Zemanova, M.; Harustiak, T.; Ehrmann, J.; Hajduch, M.; Svoboda, M.; Sachlova, M.; Slaby, O. Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus. Diagn Pathol 2015, 10, 42, doi:10.1186/s13000-015-0280-6.11. Komatsu, S.; Ichikawa, D.; Takeshita, H.; Konishi, H.; Nagata, H.; Hirajima, S.; Kawaguchi, T.; Arita, T.; Shiozaki, A.; Fujiwara, H., et al. Prognostic impact of circulating miR-21 and miR-375 in plasma of patients with esophageal squamous cell carcinoma. Expert Opin Biol Ther 2012, 12 Suppl 1, S53-59, doi:10.1517/14712598.2012.681373.12. Zhang, Y.; Guan, D.H.; Bi, R.X.; Xie, J.; Yang, C.H.; Jiang, Y.H. Prognostic value of microRNAs in gastric cancer: a meta-analysis. Oncotarget 2017, 8, 55489-55510, doi:10.18632/oncotarget.18590.13. Valladares-Ayerbes, M.; Reboredo, M.; Medina-Villaamil, V.; Iglesias-Diaz, P.; Lorenzo-Patino, M.J.; Haz, M.; Santamarina, I.; Blanco, M.; Fernandez-Tajes, J.; Quindos, M., et al. Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer. J Transl Med 2012, 10, 186, doi:10.1186/1479-5876-10-186.14. Komatsu, S.; Ichikawa, D.; Takeshita, H.; Tsujiura, M.; Morimura, R.; Nagata, H.; Kosuga, T.; Iitaka, D.; Konishi, H.; Shiozaki, A., et al. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer 2011, 105, 104-111, doi:10.1038/bjc.2011.198.15. Zhang, H.P.; Sun, F.B.; Li, S.J. Serum miR-200c expression level as a prognostic biomarker for gastric cancer. Genet Mol Res 2015, 14, 15913-15920, doi:10.4238/2015.December.7.2.16. Li, M.; Gu, K.; Liu, W.; Xie, X.; Huang, X. MicroRNA-200c as a prognostic and sensitivity marker for platinum chemotherapy in advanced gastric cancer. Oncotarget 2017, 8, 51190-51199, doi:10.18632/oncotarget.17087.17. Li, B.X.; Yu, Q.; Shi, Z.L.; Li, P.; Fu, S. Circulating microRNAs in esophageal squamous cell carcinoma: association with locoregional staging and survival. Int J Clin Exp Med 2015, 8, 7241-7250.18. Lu, Y.B.; Hu, J.J.; Sun, W.J.; Duan, X.H.; Chen, X. Prognostic value of miR-141 downregulation in gastric cancer. Genet Mol Res 2015, 14, 17305-17311, doi:10.4238/2015.December.16.31.19. Xin, S.Y.; Feng, X.S.; Zhou, L.Q.; Sun, J.J.; Gao, X.L.; Yao, G.L. Reduced expression of circulating microRNA-218 in gastric cancer and correlation with tumor invasion and prognosis. World J Gastroenterol 2014, 20, 6906-6911, doi:10.3748/wjg.v20.i22.6906.